Jazz Pharmaceuticals plc Earnings Per Share (Diluted)
Jazz Pharmaceuticals plc (JAZZ) reported Earnings Per Share (Diluted) of $2.78 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-03
- Jazz Pharmaceuticals plc earnings per share, diluted for the quarter ending 2026-06-30 was $2.78.
- Jazz Pharmaceuticals plc earnings per share, diluted for the quarter ending 2026-03-31 was $4.43.
- Jazz Pharmaceuticals plc earnings per share, diluted for the quarter ending 2025-12-31 was $3.33, a 7.21% increase year-over-year.
- Jazz Pharmaceuticals plc earnings per share, diluted for the quarter ending 2025-09-30 was $4.08, a 19.30% increase year-over-year.
- Jazz Pharmaceuticals plc earnings per share, diluted for fiscal 2025 was -$5.84, a 167.51% decline from fiscal 2024.
- Jazz Pharmaceuticals plc earnings per share, diluted for fiscal 2024 was $8.65, a 41.80% increase from fiscal 2023.
- Jazz Pharmaceuticals plc earnings per share, diluted for fiscal 2023 was $6.10.
- Jazz Pharmaceuticals plc earnings per share, diluted for fiscal 2022 was -$3.58.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.78 10-Q · filed 2026-08-03 | $7.17 10-Q · filed 2026-08-03 | |||||
| 2026-03-31 | $4.43 10-Q · filed 2026-05-05 | ||||||
| 2025-12-31 | $3.33 derived: net income ÷ weighted average shares · filed 2026-02-24 | $7.42 derived: net income ÷ weighted average shares · filed 2026-02-24 | -$4.30 derived: net income ÷ weighted average shares · filed 2026-08-03 | -$5.84 10-K · filed 2026-02-24 | |||
| 2025-09-30 | $4.08 10-Q · filed 2025-11-05 | -$7.61 derived: net income ÷ weighted average shares · filed 2026-08-03 | -$9.18 10-Q · filed 2025-11-05 | -$6.01 derived: net income ÷ weighted average shares · filed 2026-08-03 | |||
| 2025-06-30 | -$11.74 10-Q · filed 2026-08-03 | -$13.28 10-Q · filed 2026-08-03 | -$10.12 derived: net income ÷ weighted average shares · filed 2026-08-03 | -$6.54 derived: net income ÷ weighted average shares · filed 2026-08-03 | |||
| 2025-03-31 | -$1.52 10-Q · filed 2026-05-05 | $1.61 derived: net income ÷ weighted average shares · filed 2026-05-05 | $5.08 derived: net income ÷ weighted average shares · filed 2026-05-05 | $7.65 derived: net income ÷ weighted average shares · filed 2026-05-05 | |||
| 2024-12-31 | $3.11 derived: net income ÷ weighted average shares · filed 2026-02-24 | $6.53 derived: net income ÷ weighted average shares · filed 2026-02-24 | $8.97 derived: net income ÷ weighted average shares · filed 2026-02-24 | $8.65 10-K · filed 2026-02-24 | |||
| 2024-09-30 | $3.42 10-Q · filed 2025-11-05 | $5.87 derived: net income ÷ weighted average shares · filed 2025-11-05 | $5.63 10-Q · filed 2025-11-05 | $7.15 derived: net income ÷ weighted average shares · filed 2026-02-24 | |||
| 2024-06-30 | $2.49 10-Q · filed 2025-08-06 | $2.35 10-Q · filed 2025-08-06 | $3.83 derived: net income ÷ weighted average shares · filed 2026-02-24 | $6.01 derived: net income ÷ weighted average shares · filed 2026-02-24 | |||
| 2024-03-31 | -$0.23 10-Q · filed 2025-05-07 | $1.28 derived: net income ÷ weighted average shares · filed 2026-02-24 | $3.50 derived: net income ÷ weighted average shares · filed 2026-02-24 | $5.03 derived: net income ÷ weighted average shares · filed 2026-02-24 | |||
| 2023-12-31 | $1.42 derived: net income ÷ weighted average shares · filed 2026-02-24 | $3.57 derived: net income ÷ weighted average shares · filed 2026-02-24 | $5.08 derived: net income ÷ weighted average shares · filed 2026-02-24 | $6.10 10-K · filed 2026-02-24 | |||
| 2023-09-30 | $2.14 10-Q · filed 2024-11-07 | $3.65 derived: net income ÷ weighted average shares · filed 2024-11-07 | $4.67 10-Q · filed 2024-11-07 | $1.43 derived: net income ÷ weighted average shares · filed 2025-02-26 | |||
| 2023-06-30 | $1.52 10-Q · filed 2024-08-01 | $2.55 10-Q · filed 2024-08-01 | -$0.76 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$1.07 derived: net income ÷ weighted average shares · filed 2025-02-26 | |||
| 2023-03-31 | $1.04 10-Q · filed 2024-05-02 | -$2.46 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$2.81 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$2.30 derived: net income ÷ weighted average shares · filed 2025-02-26 | |||
| 2022-12-31 | -$4.01 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$4.24 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$3.64 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$3.58 10-K · filed 2025-02-26 | |||
| 2022-09-30 | -$0.31 10-Q · filed 2023-11-08 | $0.24 derived: net income ÷ weighted average shares · filed 2023-11-08 | $0.26 10-Q · filed 2023-11-08 | ||||
| 2022-06-30 | $0.55 10-Q · filed 2023-08-09 | $0.57 10-Q · filed 2023-08-09 | |||||
| 2022-03-31 | $0.03 10-Q · filed 2023-05-10 | ||||||
| 2021-12-31 | -$5.52 10-K · filed 2024-02-28 | ||||||
| 2021-09-30 | -$0.86 10-Q · filed 2022-11-09 | -$4.98 10-Q · filed 2022-11-09 | |||||
| 2021-06-30 | -$6.11 10-Q · filed 2022-08-03 | -$4.17 10-Q · filed 2022-08-03 | |||||
| 2021-03-31 | $2.09 10-Q · filed 2022-05-04 | ||||||
| 2020-12-31 | $2.33 10-K · filed 2021-02-23 | $4.22 10-K · filed 2023-03-01 | |||||
| 2020-09-30 | $2.64 10-Q · filed 2021-11-09 | $1.87 10-Q · filed 2021-11-09 | |||||
| 2020-06-30 | $2.06 10-Q · filed 2021-08-03 | -$0.77 10-Q · filed 2021-08-03 | |||||
| 2020-03-31 | -$2.82 10-Q · filed 2021-05-04 | ||||||
| 2019-12-31 | $1.29 10-K · filed 2021-02-23 | $9.09 10-K · filed 2022-03-01 | |||||
| 2019-09-30 | $1.78 10-K · filed 2021-02-23 | $7.80 10-Q · filed 2020-11-02 | |||||
| 2019-06-30 | $4.56 10-K · filed 2021-02-23 | $6.01 10-Q · filed 2020-08-04 | |||||
| 2019-03-31 | $1.47 10-K · filed 2021-02-23 | ||||||
| 2018-12-31 | $2.64 10-K · filed 2020-02-25 | $7.30 10-K · filed 2021-02-23 | |||||
| 2018-09-30 | $2.41 10-K · filed 2020-02-25 | $4.68 10-Q · filed 2019-11-05 | |||||
| 2018-06-30 | $1.50 10-K · filed 2020-02-25 | $2.26 10-Q · filed 2019-08-06 | |||||
| 2018-03-31 | $0.75 10-K · filed 2020-02-25 | ||||||
| 2017-12-31 | $3.79 10-K · filed 2019-02-26 | $7.96 10-K · filed 2020-02-25 | |||||
| 2017-09-30 | $1.03 10-K · filed 2019-02-26 | $4.17 10-Q · filed 2018-11-06 | |||||
| 2017-06-30 | $1.72 10-K · filed 2019-02-26 | $3.13 10-Q · filed 2018-08-07 | |||||
| 2017-03-31 | $1.41 10-K · filed 2019-02-26 | ||||||
| 2016-12-31 | $1.91 10-K · filed 2018-02-27 | $6.41 10-K · filed 2019-02-26 | |||||
| 2016-09-30 | $1.45 10-K · filed 2018-02-27 | $1.41 10-Q · filed 2016-11-08 | $4.51 10-Q · filed 2017-11-07 | $4.40 10-Q · filed 2016-11-08 | |||
| 2016-06-30 | $1.85 10-K · filed 2018-02-27 | $1.80 10-Q · filed 2016-08-09 | $3.05 10-Q · filed 2017-08-08 | $2.98 10-Q · filed 2016-08-09 | |||
| 2016-03-31 | $1.21 10-K · filed 2018-02-27 | $1.19 10-Q · filed 2016-05-10 | |||||
| 2015-12-31 | $1.32 10-K · filed 2017-02-28 | $5.23 10-K · filed 2018-02-27 | |||||
| 2015-09-30 | $1.39 10-K · filed 2017-02-28 | $3.91 10-Q · filed 2016-11-08 | |||||
| 2015-06-30 | $1.40 10-K · filed 2017-02-28 | $2.52 10-Q · filed 2016-08-09 | |||||
| 2015-03-31 | $1.12 10-K · filed 2017-02-28 | ||||||
| 2014-12-31 | $1.30 10-K · filed 2016-02-23 | $0.93 10-K · filed 2017-02-28 | |||||
| 2014-09-30 | $0.41 10-K · filed 2016-02-23 | -$0.39 10-Q · filed 2015-11-09 | |||||
| 2014-06-30 | $0.70 10-K · filed 2016-02-23 | -$0.83 10-Q · filed 2015-08-05 | |||||
| 2014-03-31 | -$1.58 10-K · filed 2016-02-23 | ||||||
| 2013-12-31 | $0.90 10-K · filed 2015-02-24 | $3.51 10-K · filed 2016-02-23 | |||||
| 2013-09-30 | $1.23 10-K · filed 2015-02-24 | $2.62 10-Q · filed 2014-11-04 | |||||
| 2013-06-30 | $0.69 10-K · filed 2015-02-24 | $1.39 10-Q · filed 2014-08-05 | |||||
| 2013-03-31 | $0.71 10-K · filed 2015-02-24 | ||||||
| 2012-12-31 | $3.28 10-K · filed 2014-02-25 | $4.79 10-K · filed 2015-02-24 | |||||
| 2012-09-30 | $0.55 10-K · filed 2014-02-25 | $1.47 10-Q · filed 2013-11-05 | |||||
| 2012-06-30 | $0.45 10-K · filed 2014-02-25 | $0.92 10-Q · filed 2013-08-06 | |||||
| 2012-03-31 | $0.48 10-K · filed 2014-02-25 | ||||||
| 2011-12-31 | $0.79 10-K · filed 2012-02-28 | $2.67 10-K · filed 2014-02-25 | |||||
| 2011-09-30 | $0.69 10-Q · filed 2012-11-09 | $1.88 10-Q · filed 2012-11-09 | |||||
| 2011-06-30 | $0.71 10-Q · filed 2012-08-07 | $1.19 10-Q · filed 2012-08-07 | |||||
| 2011-03-31 | $0.48 10-Q · filed 2012-05-08 | ||||||
| 2010-12-31 | $0.79 10-K · filed 2013-02-26 | $0.56 10-K · filed 2012-02-28 | $0.83 10-K · filed 2013-02-26 | ||||
| 2010-09-30 | $0.69 10-K · filed 2013-02-26 | $0.32 10-Q · filed 2011-11-08 | $0.22 10-Q · filed 2011-11-08 | ||||
| 2010-06-30 | $0.71 10-K · filed 2013-02-26 | -$0.18 10-Q · filed 2011-08-03 | -$0.15 10-Q · filed 2011-08-03 | ||||
| 2010-03-31 | $0.48 10-K · filed 2013-02-26 | $0.04 10-K · filed 2012-02-28 | |||||
| 2009-12-31 | -$0.23 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |